Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Elicera Therapeutics enters into agreement with Baylor College of Medicine for contract manufacturing of next generation oncolytic virus, ELC-201

Gothenburg, December 15, 2021 - Elicera Therapeutics AB (publ) (“Elicera”), a clinical stage cell and gene therapy company developing immuno-oncological treatments using enhanced CAR T-cells and oncolytic viruses, announced today that it has signed an agreement with Baylor College of Medicine (BCM), Center for Cell & Gene Therapy regulating contract manufacturing of ELC-201, the company's next generation oncolytic virus armed with Elicera’s fully developed iTANK-platform for a multi-targeted attack on cancer.This is the second collaboration between Elicera and Baylor College of Medicine (

Husqvarna Group increases ownership in Yeti Move – providing an autonomous software platform to airports

Husqvarna Group has increased its ownership in Yeti Move, a software solution provider, providing an autonomous platform to airports and other industries. The Yeti system is sold and currently under commissioning at both Oslo and Stockholm airport for snow clearing operations. Combined with other solutions from the Husqvarna Group, including robotic mowers, the aim is to provide operators with a comprehensive autonomous solution for all seasons. Husqvarna Ventures , a part of Husqvarna Group, invests in strategically relevant start-up

DSRT: Desert Control and Mawarid Enter into Agreement to Form a New Company

ISSUER DESERT CONTROL AS Sandnes, Norway/Abu Dhabi, United Arab Emirates, 15 December 2021.Reference is made to the stock exchange releases published by Desert Control AS("Desert Control" or the "Company") on 8 June 2021, announcing the Memorandum ofUnderstanding ("MOU") with Mawarid Holding Investment and its subsidiaries,including Barari Natural Resources ("Mawarid"), and further on 21 October 2021,announcing that Desert Control extended its agreement with Mawarid and waspreparing for stage two of the MOU. Stage two includes the establishment of astrategic partnership

The Hanz development sanctioned

Aker BP (operator) and licence partners Equinor and Spirit Energy have affirmed the investment decision (DG3) for development of the Hanz discovery in the North Sea. The project has matured a solution involving reuse of existing infrastructure, which both strengthens project economics and minimises the environmental footprint. Hanz is an oil and gas discovery that will be tied into the Ivar Aasen platform about twelve kilometres further south. Total investments are estimated at NOK 3.3 billion. Expected start-up is in the first half of 2024. Total reserves are around 20 million

Concordium airdrops $2.5 million worth of tokens towards decentralization of $CCD

Zurich, December 14, 2021: Concordium, the layer 1 blockchain with an ID layer at the protocol level, has announced an airdrop of 4,500,000 of its CCD token, worth $2,5 million to all the users who have downloaded their wallet. Concordium CEO Lone Fønss Schrøder explained the reasoning behind the airdrop: “This airdrop is part of Concordium’s further plans of decentralization of the network and follows the successful initial airdrop that we created for our core original founding community.” “By awarding tokens to our faithful community and new members we help users and developers with

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 114 - 15 DECEMBER 2021 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp participates by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in Dampskibsselskabet NORDEN A/S. The market will be informed accordingly – see the attached file and announcement no. 75/2021. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information:Thomas France, Investor Communications Partner, tlf.: 3315 0451

eBusiness Institute and Lingaro combine forces to deliver first-class digital solutions

Geneva, December 15, 2021 - Geneva-based eBusiness Institute today announces its acquisition by global data and analytics company, Lingaro Group. This powerful union, shaking up the already competitive landscape of digital consulting companies, will set new standards for delivering first-class end-to-end digital transformation solutions built around insights from factual data and analytics.According to Gartner’s 2021 research, more than 80% of marketing executives are disappointed with their current innovation implementation status. They lack the technology and digital marketing expertise

Notification of transactions by persons discharging managerial responsibilities and persons closely associated with them in Penneo A/S

Company Announcement No. 30-2021Copenhagen, 15 December 2021 In accordance with the Market Abuse Regulation, Penneo must notify Finanstilsynet and publicly disclose transactions made by persons discharging managerial responsibilities and persons closely associated with them on trading of Penneo shares. Penneo hereby notify and submit the following transaction of shares in Penneo: Name: André Clément Holding ApSTitle: Legal person closely associated with André Clément (Chief Commercial Officer of

CELLINK and Nanoscribe join forces to launch the Quantum X bio, the world’s most accurate 3D bioprinter

The Quantum X bio combines CELLINK’s bioprinting expertise with the engineering excellence of Nanoscribe to create a first-of-Its-kind bioprinter Today, BICO companies CELLINK and Nanoscribe announced the launch of the Quantum X bio, a revolutionary printing platform providing researchers with first-of-its-kind submicron bioprinting resolution. Powered by Two Photon Polymerization (2PP), the Quantum X bio is the premier tool for miniaturizing bioprinting, redefining what it means to work within advanced biomedical applications, including tissue engineering and regenerative medicine.

BioStock: Abliva on the IND-approval from FDA

A few weeks ago, the US Food and Drug Administration approved Abliva’s Investigational New Drug application for KL1333, enabling the start of a registrational phase II/III study with first patients due to be recruited in 2022. BioStock reached out to Magnus Hansson, CMO & VP Preclinical and Clinical Development, for a comment.Read the interview with Magnus Hansson at biostock.se: https://www.biostock.se/en/2021/12/abliva-on-the-ind-approval-from-fda/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

To the moon and beyond – SSC takes years of lunar experience into the future

The moon has been a focal point for the space industry since the 1950’s. Early on, SSC joined the lunar race and the company has gathered extensive experience as the world’s first commercial lunar communications service. Now, SSC is preparing for future lunar missions in the coming years, supporting commercial missions to the moon, including for Astrobotic, Masten Space Systems and Firefly Aerospace in the U.S. “With the lunar legacy that lies within this company, dating all the way back to the Apollo program, we are confident to take on the future of lunar and deep-space missions. Our

Preliminary assessment of received acceptances in Murgröna Holding’s public offer to the shareholders of ICA Gruppen

THIS PRESS RELEASE MAY NOT, DIRECTLY OR INDIRECTLY, BE DISTRIBUTED OR PUBLISHED IN OR INTO ANY JURISDICTION (INCLUDING WITHOUT LIMITATION AUSTRALIA, CANADA, CHINA, HONG KONG, JAPAN, MEXICO, NEW ZEALAND, SINGAPORE, SOUTH AFRICA OR SWITZERLAND) WHERE THE DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE IN CONFLICT WITH ANY APPLICABLE LAWS OR REGULATIONS. THE OFFER IS NOT BEING MADE TO (AND ACCEPTANCE FORMS WILL NOT BE ACCEPTED FROM OR ON BEHALF OF) PERSONS WHOSE PARTICIPATION IN THE OFFER WOULD REQUIRE THAT ANY OFFER DOCUMENTS ARE PREPARED, FILINGS ARE EFFECTUATED OR OTHER MEASURES

Dignitana publishes December newsletter

Dignitana AB today publishes the December newsletter highlighting progress with reimbursement, increased awareness through media coverage, and new locations in the U.S. To read the newsletter click here  or visit Dignitana.com .The Dignitana InBrief newsletter is published monthly and posted at www.dignitana.com as part of Dignitana's commitment to provide ongoing communication to the market. To receive future Dignitana news directly to your email, subscribe here 

BioStock: Stayble Therapeutics strengthened in 2021

In 2021, Stayble Therapeutics made progress in the development of a disease-modifying injection treatment for chronic discogenic low back pain. During the year, Stayble Therapeutics was strengthened with the recruitment of several key persons and an oversubscribed share issue. Finally, they were able to present positive interim results from the phase IIb study with STA363. BioStock contacted CEO Andreas Gerward to get his thoughts on the past year and what to expect next.Read the interview with Stayble Therapeutics' CEO Andreas Gerward at biostock.se: https://www.biostock.se/en/2021/12/

Mandatory notification of trade

On December 14[th] 2021, DNB has, on behalf of Otello Corporation, purchased 740 shares for use in the group's employee share purchase plan (ESPP). The shares have been acquired at a price of NOK 27.00. The discounted share price to the employees is NOK 21.60 per share. The following primary insiders have purchased shares: Scott Andrew Kerrison purchased 740 shares at NOK 21.60. As of today the primary insider holds 740 shares in the Company.

Realheart's artificial heart becomes 10-20 percent smaller

Realheart is developing the world's first four-chamber artificial heart. Now the company's design team has identified an opportunity to make the heart 10-20 percent smaller in size, which could have a major impact on future patients and on Realheart's future market.Realheart's research and development work is conducted in three legs: digitally, in the laboratory, and through anatomical and animal studies, all of which are progressing in parallel. During this autumn's animal studies, the pump was again confirmed to work well. At the same time, the design team discovered in laboratory

Mandatory notification of trade

Anooj Unarket, Board member of Otello Corporation ASA, has on behalf of certain related parties, as of 14th December 2021, acquired interests in shares of Otello Corporation ASA. The balance of Anooj Unarket and related parties’ holdings after the transaction totals 26,581,770 shares. Please refer to the attached notification of trading for further details. This information is subject to disclosure requirements in regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12.

Safello Adds Polygon and Polkadot to Its Cryptocurrency Offering

Stockholm, 15 December 2021 | Swedish fintech Safello  today announced it is expanding its support for cryptocurrencies to include Polygon and Polkadot. The news comes shortly after the successful launch of Chainlink that showed a spike in interest. Safello now offers five currencies: Bitcoin (BTC), Ethereum (ETH), Chainlink (LINK), Polygon (MATIC) and Polkadot (DOT). Safello is currently the only Swedish crypto company to offer direct investment in Polygon and Polkadot. Furthermore, Safello is the only Sweden based entry point to Polygon as the currency is not

Truecaller increases focus and investments in the iPhone product through a fully redesigned interface

Truecaller, the leading global platform for verifying contacts and blocking unwanted communication, is pleased to announce the roll-out of a completely new design of Truecaller for iPhone. The new interface is simplified, easy to use and enhances the search engine function that is used by millions of Truecaller users on iPhone every day. The recent enhancement is the first step in a bigger initiative to provide the best user experience on iPhone for consumers and enterprises.“We put a lot of emphasis on improving the experience of Truecaller on iPhone with our increased, long-term focus on

BioStock: Spago Nanomedical prepares for an eventful 2022

Lund-based Spago Nanomedical has completed the pre-clinical programme with SN201, the candidate drug in the cancer treatment project Tumorad. Reaching this milestone,together with the completion of the second cohort in the SPAGOPIX-01 study, the company ends the year on a high note as it prepares for an eventful 2022. BioStock reached out to CEO Mats Hansen to find out more.Read the interview with Spago Nanomedical's CEO Mats Hansen at biostock.se: https://www.biostock.se/en/2021/12/spago-nanomedical-prepares-for-an-eventful-2022/ This is a press release from BioStock - Connecting

Brain+ lands first large-pharma partnership deal to enter the German market for dementia products

BRAIN+ A/S (BRAINP) Company Announcement No. 4-2021 Wednesday, December 15, 2021, 8:20 CET The information communicated in this announcement is “inside information” for the purposes of article 7 of the Market Abuse Regulation 596/2014 Brain+ has signed a partnership agreement with RoX Health , a subsidiary of the global pharma company Roche in Germany, to bring its first dementia products to the German market.Germany is the largest and most interesting EU market to Brain+: More than 1.5 million people are living with dementia in Germany. With new and

Help with your Swedish tax returns—how to calculate the acquisition cost for Sectra redemption shares 2021

Linköping, Sweden, December 15, 2021 – The Annual General Meeting of the international medical imaging IT and cybersecurity company Sectra  (STO: SECT B) resolved to carry out a redemption program according to which SEK 0.90 per share was distributed to Sectra shareholders in November 2021. According to the general advice issued by the Swedish Tax Agency regarding the redemption program, 99.5% of the acquisition cost for an original Class A or Class B share in Sectra AB should be attributed to remaining shares and 0.5% to redemption shares of the respective class.

There are no items matching the current filter
There are no more items matching the current filter
Back to top